KAITLIN MEIER: Open Payments
NPI 1194216168 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$553 in 8 payments from 4 companies in 2025. Trend: 2023 $594 · 2024 $744 · 2025 $553
Food & beverage: $553
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 2 | $255 |
| Janssen Biotech, Inc. | 3 | $237 |
| Ipsen Biopharmaceuticals, Inc | 2 | $40 |
| ABBVIE INC. | 1 | $21 |
Products named: Livdelzi, TREMFYA, IQIRVO, MAVYRET.
Industry payments across WI — which companies pay providers there.
